TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$0.78+0.02 (+2.36%)
Close on Nov 18, 2026Market cap $35.02MP/E –Yield –
TELA Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
TELA Bio's enterprise value was $67.88M on Nov 11, 2026, against $58.17M a year earlier. Over the last 5 years it ranged from $26.40M to $211.38M, with a median of $98.31M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $67.88M | +14.3% |
| 2025 | Dec 31, 2025 | $59.38M | -39.6% |
| 2024 | Dec 31, 2024 | $98.31M | -31.9% |
| 2023 | Dec 29, 2023 | $144.27M | -29.9% |
| 2022 | Dec 30, 2022 | $205.87M | +56.0% |
| 2021 | Dec 31, 2021 | $132.01M | -2.6% |
| 2020 | Dec 31, 2020 | $135.59M | – |
| 2019 | Dec 31, 2019 | -$13.45M | – |
See a number that looks wrong?